Filing Details
- Accession Number:
- 0001708138-20-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:03:37
- Reporting Period:
- 2020-05-06
- Accepted Time:
- 2020-05-08 16:03:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437435 | Marc Tessier-Lavigne | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-06 | 15,000 | $177.82 | 16,830 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-06 | 1,025 | $562.65 | 15,805 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 6,375 | $563.45 | 9,430 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 6,600 | $564.45 | 2,830 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 900 | $565.35 | 1,930 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 100 | $566.01 | 1,830 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-05-06 | 15,000 | $0.00 | 15,000 | $177.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-01-02 | No | 4 | M | Direct |
Footnotes
- Represents volume-weighted average price of sales of 1,025 shares of Company stock on May 6, 2020 at prices ranging from $562.12 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price.
- Represents volume-weighted average price of sales of 6,375 shares of Company stock on May 6, 2020 at prices ranging from $563.00 to $563.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price.
- Represents volume-weighted average price of sales of 6,600 shares of Company stock on May 6, 2020 at prices ranging from $564.00 to $564.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price.
- Represents volume-weighted average price of sales of 900 shares of Company stock on May 6, 2020 at prices ranging from $565.00 to $565.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
